In a world where computing power and other technologies are continually evolving, contact lenses are no different. We are continually launching advanced lenses, thus a major part of our business is in research and development.

In December 2006, UltraVision celebrated the opening of a new R&D facility in Cambridge, UK.

'Significant investment in R & D is key to our strategic intent to continue to bring innovative products to market and to offer further licensing opportunities to third party contact lens manufacturers worldwide' said J Keith Lomas the company's Group President and Chief Executive Officer.

An example of UltraVision's innovative approach is the Queen's Awards for Enterprise: Innovation, bestowed in both 2010 for KeraSof® and in 2006, for UltraVision's Wavefront and SAM® (Spherical Aberration Management) technologies.

John Clamp, Group Vice President and Chief Operations Officer of UltraVision commented that, 'the Company currently invests 15% of a growing turnover in R & D to ensure a rich pipeline of new products over the next three to five years, and will continue to do so in the future.'

UltraVision utilises the best on offer, in terms of: